ALK非小細胞肺癌の頭蓋内反応 薬剤性肝炎によるアレクチニブ中止後の第二選択用量エスカレートブリガチニブに対する反応と、定位放射線手術後の全脳放射線治療後の再発

Intracranial Response of ALK Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery.

• Edyta Maria Urbanska
• Eric Santoni-Rugiu
• Linea Cecilie Melchior
• Jonathan Frederik Carlsen
• Jens Benn Sørensen

抄録